NASDAQ:PRGS Archives - Benchmark Monitor

Markets

Investments Worthy Stock: vTv Therapeutics Inc. (NASDAQ:VTVT), Progress Software Corporation (NASDAQ:PRGS), The Goldman Sachs Group, Inc. (NYSE:GS), The Bank of New York Mellon Corporation (NYSE:BK)

June 28, 2019June 28, 2019

vTv Therapeutics Inc. (NASDAQ:VTVT) initiated its Phase 2 clinical trial for evaluating azeliragon in patients with mild Alzheimer’s disease and Type 2 Diabetes. vTv Therapeutics …